Anna Voltura, MD
Surgery · Santa Fe, NMNPI 1285784140
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 27.8% of the total.
Across 109 payments — averaging $34.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sirius Medical Systems$850
- AstraZeneca$238
- Merck$223
- Merit Medical Systems Inc$206
- Novartis$202
- plus $972 from 25 others
What the payments were for
- Food & beverage$3,727100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $1,036 |
| Sirius Medical Systems | 8 | $850 |
| AstraZeneca(2 entities) | 12 | $238 |
| Merck | 9 | $223 |
| Merit Medical Systems Inc | 2 | $206 |
| Novartis | 9 | $202 |
| Johnson & Johnson | 6 | $109 |
| Vertex | 3 | $93 |
| Incyte Corporation | 4 | $84 |
| Exelixis Inc. | 3 | $61 |
| Sanofi | 4 | $59 |
| AVEO Pharmaceuticals, Inc. | 2 | $53 |
| Hologic Sales And Service, LLC | 1 | $49 |
| Exeltis, USA Inc. | 2 | $48 |
| Genmab U.S., Inc. | 2 | $45 |
| Eisai Inc. | 2 | $45 |
| Pfizer | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Tersera Therapeutics LLC | 1 | $28 |
| Bayer | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Tempus AI, Inc | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $19 |
| Medtronic | 1 | $17 |
| Stryker | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PINTUITION$805
- NATRELLE SALINE-FILLED BREAST IMPLANTS$262
- Savi SCOUT$124
- SAVI BRACHY$124
How this compares
$3,727 in reported general payments places this provider in the 65th percentile of 162 surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamoxifen Citrate | 18 | $441 |
| Anastrozole | 14 | $296 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other surgery in Santa Fe
- Jose SterlingSanta Fe$20K
- Nicholas SutherlandSanta Fe$11K
- Mario LeybaAlbuquerque$1.2M
- Michael BleaAlbuquerque$420K
- David HoangAlbuquerque$264K
- Erica McBrideAlbuquerque$95K
- Fermin FontanLas Cruces$87K
- Gregory BorahAlbuquerque$77K
- Edward AuyangAlbuquerque$70K
- Jacquelyn BrandenburgAlbuquerque$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.